Hutch News

For many blood cancer patients, CAR T-cell therapy is game-changing

For many blood cancer patients, CAR T-cell therapy is game-changing

In this episode of From Bench to Bedside and Beyond, Dr. Mazyar Shadman explains why CAR T-cell therapy should be considered for patients who relapse
Hutch NewsDecember 02, 2025
For Fred Hutch biostatisticians, numbers are no game

For Fred Hutch biostatisticians, numbers are no game

Meticulous work at the SWOG Statistics and Data Management Center, housed at Fred Hutch, may alter care for bladder cancer and lymphoma
Hutch NewsOctober 17, 2024
Cancer, COVID-19 and proceeding with caution

Cancer, COVID-19 and proceeding with caution

Patients in treatment and those with compromised or suppressed immune systems eye the future — and pandemic’s wane — warily
Hutch NewsFebruary 16, 2022
Vaccination after CAR-T-cell therapy

Vaccination after CAR-T-cell therapy

From the Hill group, Vaccine and Infectious Disease Division and the UW/Fred Hutch Cancer Consortium
Science SpotlightDecember 20, 2021